joim12183-sup-0001-FigureS1-S3.docxWord document436K

Figure S1 Presentation values of 6 miRNAs in (a) patients with AMI (n= 224) and without AMI (n=931); (b) patients with STEMI (n= 45) and NSTEMI (n=179).

Figure S2 ROC curves displaying diagnostic accuracy for (a) 6 miRNAs, (b–c) miR-208b and miR-499 in comparison and combination with a conventional (cTnT4, Roche Diagnostic) and high-sensitivity cardiac Troponin assay (hs-cTnT, Roche Diagnostics), (d) 6 miRNAs in early presenters (presenting within 3 hours from symptom onset).

Figure S3 Kaplan Meier curves for survival in all acute chest pain patients displaying cumulative survival during short-term follow-up (30 days) and long-term follow-up (730 days), subdivided into 2 groups according to optimal cut-off (-10.38) by Youden index (sensitivity of 31.8%, specificity of 86.2%). Log-rank values were employed to assess statistical significance. miRNA values are log-transformed.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.